Skip to main content

November 2 Weekly CIRT Campus Update

CIRT Update

Published November 2, 2021

Dear students, staff and faculty:

Below, please find important campus, regional and national updates from the COVID-19 Incident Response Team (CIRT). 

Campus Status

Over the past seven days, there has been four positive cases of COVID-19 reported through the on-campus campus screening program. For more data on the screening program, please visit Coronavirus Screening.

Employee Flu Vaccines

The Schacht Center is partnering with a local pharmacy to provide flu vaccinations to employees on Wednesday, November 3, from 8 a.m. to 4:30 p.m. in the Campus Center, rooms 103 and 104. Please use this link to sign up for a time to receive your vaccination. Bring a copy of your insurance card and plan to arrive 5-10 minutes early to complete a registration form.

Vaccination Update

The FDA has authorized the use of Pfizer vaccine for children aged 5-11. Please monitor https://www.cdc.gov/vaccines/covid-19/planning/children.html to track further regulatory announcements. 

Booster Updates 

The college continues to monitor federal guidance around COVID-19 booster shots. Those eligible to receive booster shots should visit https://vaxfinder.mass.gov/ for vaccine booster locations. 

Pfizer and Moderna

Individuals in the following groups are eligible to receive a booster shot at least six months after completion of their primary two dose series:

Johnson & Johnson/Janssen

All individuals 18 and older are able to receive a booster shot at least two months after their J&J/Janssen vaccine:

CDC recommendations also allow for mixing and matching of different COVID-19 booster doses. Eligible individuals may choose which booster vaccine they want. Some people may want the type they originally received; others may prefer to get a different booster.

Smith employees: Following the Massachusetts Department of Public Health guidance, people aged 18 or older who work in higher education are eligible for booster doses 6 months after completion of their Pfizer or Moderna primary series.

COVID-19 Incident Response Team (CIRT)

covid19info@smith.edu



134